Cardiovascular Systems, Inc. (NASDAQ:CSII) Analyst Ratings as of Apr 17, 2018

April 17, 2018 - By Mark Mitchell

During 2017 Q4 the big money sentiment increased to 1.02. That’s change of 0.23, from 2017Q3’s 0.79. 17 investors sold all, 41 reduced holdings as Cardiovascular Systems, Inc. ratio increased. 45 increased holdings while 14 funds took holdings. Funds hold 26.16 million shares thus 5.38% more from 2017Q3’s 24.82 million shares.
Mairs Pwr invested 0.02% in Cardiovascular Systems, Inc. (NASDAQ:CSII). Meeder Asset Management Inc accumulated 29,477 shs. Principal Financial Gru has 16,372 shs for 0% of their capital. Zurcher Kantonalbank (Zurich Cantonalbank) reported 2,877 shs stake. Monarch Partners Asset Management Ltd Liability Corp owns 163,755 shs. Point72 Asset Mgmt L P owns 367,000 shs for 0.04% of their capital. Bank & Trust Of America Corporation De owns 4,849 shs or 0% of their US capital. Ubs Asset Americas Incorporated holds 0% of its capital in Cardiovascular Systems, Inc. (NASDAQ:CSII) for 9,115 shs. Numeric Invsts Ltd Liability invested in 132,167 shs. Renaissance Ltd Liability accumulated 899,300 shs. Moreover, Jennison Assocs Limited Liability has 0% invested in Cardiovascular Systems, Inc. (NASDAQ:CSII). Parametric Port Associates Ltd Llc has 0% invested in Cardiovascular Systems, Inc. (NASDAQ:CSII). Fred Alger accumulated 255,567 shs. Millennium Limited Liability Corporation accumulated 0% or 123,986 shs. Thrivent For Lutherans has invested 0.01% of its capital in Cardiovascular Systems, Inc. (NASDAQ:CSII).

Cardiovascular Systems, Inc. (NASDAQ:CSII) Ratings Coverage

In total 3 analysts cover Cardiovascular Systems (NASDAQ:CSII). “Buy” rating has 1, “Sell” are 0, while 2 are “Hold”. 33% are bullish. 3 are the (NASDAQ:CSII)’s analyst reports since December 15, 2017 according to StockzIntelligence Inc. On Friday, December 15 the stock of Cardiovascular Systems, Inc. (NASDAQ:CSII) earned “Hold” rating by Needham. On Thursday, December 21 the rating was initiated by William Blair with “Hold”. On Thursday, February 8 the stock of Cardiovascular Systems, Inc. (NASDAQ:CSII) earned “Outperform” rating by Leerink Swann. Listed here are Cardiovascular Systems, Inc. (NASDAQ:CSII) PTs and latest ratings.

08/02/2018 Broker: Leerink Swann Old Rating: Outperform New Rating: Outperform Old Target: $31 New Target: $30 Maintain
21/12/2017 Broker: William Blair Rating: Hold Initiate
15/12/2017 Broker: Needham Old Rating: Buy New Rating: Hold Downgrade

The stock decreased 0.87% or $0.2 during the last trading session, reaching $22.69.Cardiovascular Systems, Inc. has volume of 108,357 shares. Since April 17, 2017 CSII has declined 21.67% and is downtrending. CSII underperformed by 33.22% the S&P 500.

Cardiovascular Systems, Inc., a medical technology company, develops, makes, and markets devices to treat vascular diseases in the United States.The firm is valued at $753.72 million. The firm offers peripheral arterial disease products, including Diamondback 360 Peripheral Orbital Atherectomy System , Diamondback 360 60cm Peripheral OAS, Diamondback 360 4 French 1.25 Peripheral OAS, Diamondback 360 1.50 Peripheral OAS, Diamondback 360 2.00 Peripheral OAS, and Stealth 360 Peripheral OAS, which are catheter platforms for treating a range of plaque types in leg arteries above and below the knee, including calcified plaque, as well as address various limitations associated with surgical, catheter, and pharmacological treatment alternatives.Last it reported negative earnings. It also provides Diamondback 360 Coronary OAS, an atherectomy device for the treatment of calcified coronary arteries.

Cardiovascular Systems, Inc. (NASDAQ:CSII) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: